Wednesday, April 25, 2007

Genzyme earnings rise on higher drug sales

(Reuters) - Excluding one-time items, the company earned 78 cents a share. Analysts on average had expected 74 cents, according to Reuters Estimates.

The company boosted its 2007 earnings forecast to a range of $3.20 to $3.30 a share, from a previous forecast of $3.05 to $3.15.


Read more at Reuters.com Market News

No comments: